Alexander O. Schuth Denali Therapeutics Inc. (DNLI) insider trading activity

DNLI Quotes by TradingView

Alexander O. Schuth is COFO and Secretary of Denali Therapeutics Inc.. Currently has a direct ownership of 282,828 shares of DNLI, which is worth approximately $4.93 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 17,218 shares (Common Stock) at a price of $16.5 per share, resulting in proceeds of $284,097. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 283K
16.7% 3M change
15.77% 12M change
Total Value Held $4.93 Million

Alexander O. Schuth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
SELL
Open market or private sale
$284,097 $16.5 p/Share
17,218 Reduced 5.74%
282,828 Common Stock
Jan 03 2026
BUY
Grant, award, or other acquisition
-
57,700 Added 16.13%
300,046 Common Stock
Aug 12 2025
SELL
Open market or private sale
$39,884 $13.58 p/Share
2,937 Reduced 1.2%
242,346 Common Stock
Jan 07 2025
SELL
Open market or private sale
$60,494 $20.81 p/Share
2,907 Reduced 1.18%
244,308 Common Stock
Jan 06 2025
SELL
Open market or private sale
$247,796 $20.22 p/Share
12,255 Reduced 4.72%
247,215 Common Stock
Jan 03 2025
BUY
Grant, award, or other acquisition
-
54,180 Added 17.27%
259,470 Common Stock
Dec 27 2024
BUY
Exercise of conversion of derivative security
$35,418 $5.28 p/Share
6,708 Added 3.16%
205,290 Common Stock
Nov 22 2024
BUY
Exercise of conversion of derivative security
$13,950 $0.68 p/Share
20,516 Added 9.36%
198,582 Common Stock
Nov 07 2024
SELL
Open market or private sale
$475,452 $30.56 p/Share
15,558 Reduced 8.04%
178,066 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
$82,146 $5.28 p/Share
15,558 Added 7.44%
193,624 Common Stock
Aug 21 2024
SELL
Open market or private sale
$63,114 $24.78 p/Share
2,547 Reduced 1.41%
178,066 Common Stock
Aug 20 2024
SELL
Open market or private sale
$137,428 $23.67 p/Share
5,806 Reduced 3.11%
180,613 Common Stock
Aug 13 2024
SELL
Open market or private sale
$52,006 $22.89 p/Share
2,272 Reduced 1.2%
186,419 Common Stock
Feb 14 2024
SELL
Open market or private sale
$355,460 $17.66 p/Share
20,128 Reduced 9.7%
187,341 Common Stock
Feb 13 2024
SELL
Open market or private sale
$46,959 $17.29 p/Share
2,716 Reduced 1.29%
207,469 Common Stock
Feb 08 2024
BUY
Exercise of conversion of derivative security
$34,000 $0.68 p/Share
50,000 Added 19.22%
210,185 Common Stock
Jan 03 2024
BUY
Grant, award, or other acquisition
-
53,720 Added 24.0%
170,157 Common Stock
Jan 04 2023
SELL
Open market or private sale
$83,574 $28.7 p/Share
2,912 Reduced 1.91%
149,828 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
41,120 Added 20.69%
157,578 Common Stock
Aug 09 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 15.63%
121,458 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
31,000 Added 20.88%
117,454 Common Stock
Sep 20 2021
BUY
Exercise of conversion of derivative security
$6,151 $0.68 p/Share
9,045 Added 8.65%
95,499 Common Stock
AOS

Alexander O. Schuth

COFO and Secretary
South San Francisco, CA

Track Institutional and Insider Activities on DNLI

Follow Denali Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

News

Receive news related to Denali Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DNLI